ORPHA — Orphazyme A/S Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Orphazyme A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	124	727	102	38.9	11.3
Net Total Accounts Receivable
Net Total Receivables	5.5	5.5	36.5	16.2	1.1
Prepaid Expenses
Total Other Current Assets
Total Current Assets	148	784	159	56.8	19.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.6	19.5	8.42	0	0
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	181	822	173	56.8	19.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	66	167	129	15.8	5.07
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	128	202	164	15.9	5.07
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	53	621	9.34	41	14.2
Total Liabilities & Shareholders' Equity	181	822	173	56.8	19.3
Total Common Shares Outstanding